Verve Therapeutics (VERV) with Maxx Chatsko
Verve Therapeutics develops gene-editing medicines for patients to treat cardiovascular diseases. Generally, biopharma companies are very difficult to understand, but today our guest makes the complex seem simple. Maxx brings his expert knowledge of Verve Therapeutics for a great discussion regarding the history and future of the company. Enjoy the show! Our Thursday Deep Dives are sponsored by Quartr, the new way of doing company research. Access conference calls, presentations, transcripts, and more for FREE on your mobile device. Download Quartr on the App Store here…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.